ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$2.00
-0.12 (-5.66%)
As of Mar 29, 10:34 PM ET ·
Analyst Consensus
Sell
13
Analysts
Moderate
Coverage
Buy 1 8%
Hold 7 54%
Sell 5 38%
Price Target
Analyst Price Target +965.0% upside
Low Target $14.71
Average Target $21.30
High Target $34.17
Current Price $2.00
Current
$2.00
Target
$21.30
$14.71 $21.30 avg $34.17
Scenario Analysis
Bear Case
$14.71
635.5%
Low target
Base Case
$21.30
+965.0%
Avg target
Bull Case
$34.17
+1,608.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$28.67
-93.0% from high
52-Week Low
$10.08
+-80.2% from low
Target vs 52W High
$21.30
-25.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%